SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) -- Biora Therapeutics, a biotech company developing the first swallowable autoinjector, today announced significant progress with its BioJet ™ platform, a ...

SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE)-- Biora Therapeutics, a biotech company developing the first swallowable autoinjector, today announced significant progress with its BioJet ™ platform, a ...

SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE)-- Biora Therapeutics, a biotech company developing the first swallowable autoinjector, today announced significant progress with its BioJet™ platform, a ...

New car sales in the USA appear to be cooling off in the first quarter, with affordability pressures tightening their grip. Rising gas prices, now hovering at levels not seen in more than three years, ...

On March 16, 2026, Celltrion, Inc. announced the U.S. commercial launch of AVTOZMA® (tocilizumab-anoh) SC, a subcutaneous formulation of its tocilizumab biosimilar referencing Roche’s ACTEMRA.

Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a global ...

Sempresto, Inc., a company developing a next-generation platform for smartphone-integrated rescue medications, today announced that it has been featured in a recent Inc. article by Chloe Capital, ...

When he was 5 years old, his mother thought he was just being picky. Growing up in a Panamanian Afro-Latino household outside of Chicago in the 1980s, refusing food was considered wasteful. So when ...

Castagna stated, "We see a clear path to over $450 million revenue run rate in 2026 alone," emphasizing commercial catalysts including Afrezza pediatric approval and FUROSCIX ReadyFlow Autoinjector ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo Nordisk in the obesity drug race. While Novo’s shares have struggled this ...

Many people living with rheumatoid arthritis (RA) rely on long-term medications to manage joint pain, stiffness, and inflammation. A number of these treatments are given as subcutaneous injections, ...